BLCO vs SNY
Bausch + Lomb Corp (BLCO) versus SNY (SNY) — a side-by-side from cached financials, not a winner call.
Bausch + Lomb Corp (BLCO) is a medical instruments & supplies company listed on NYSE.
SNY (SNY) common stock.
Latest reported BLCO revenue for 2025-12-31 was $5.10B. Net income was -$360.0M. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. BLCO currently screens at market cap $5.38B.
SNY does not have a complete income-statement cache yet.
BLCO currently screens at market cap $5.38B. SNY currently screens at market cap $0.
Not investment advice. Open the BLCO and SNY stock pages for the full models.
Not investment advice.